Zhang C, Rønnekleiv OK, Kelly MJ. Kisspeptin inhibits a slow afterhyperpolarization current via protein kinase C and reduces spike frequency adaptation in GnRH neurons. Am J Physiol Endocrinol Metab 304: E1237-E1244, 2013. First published April 2, 2013; doi:10.1152/ajpendo.00058.2013.-Kisspeptin signaling via its cognate receptor G protein-coupled receptor 54 (GPR54) in gonadotropin-releasing hormone (GnRH) neurons plays a critical role in regulating pituitary secretion of luteinizing hormone and thus reproductive function. GPR54 is Gq-coupled to activation of phospholipase C and multiple second messenger signaling pathways. Previous studies have shown that kisspeptin potently depolarizes GnRH neurons through the activation of canonical transient receptor potential channels and inhibition of inwardly rectifying K ϩ channels to generate sustained firing. Since the initial studies showing that kisspeptin has prolonged effects, the question has been why is there very little spike frequency adaption during sustained firing? Presently, we have discovered that kisspeptin reduces spike frequency adaptation and prolongs firing via the inhibition of a calcium-activated slow afterhyperpolarization current (IsAHP). GnRH neurons expressed two distinct IsAHP, a kisspeptin-sensitive and an apamin-sensitive IsAHP. Essentially, kisspeptin inhibited 50% of the IsAHP and apamin inhibited the other 50% of the current. Furthermore, the kisspeptin-mediated inhibition of IsAHP was abrogated by the protein kinase C (PKC) inhibitor calphostin C, and the PKC activator phorbol 12,13-dibutyrate mimicked and occluded any further effects of kisspeptin on IsAHP. The protein kinase A (PKA) inhibitors H-89 and the Rp diastereomer of adenosine 3=,5=-cyclic monophosphorothioate had no effect on the kisspeptin-mediated inhibition but were able to abrogate the inhibitory effects of forskolin on the IsAHP, suggesting that PKA is not involved. Therefore, in addition to increasing the firing rate through an overt depolarization, kisspeptin can also facilitate sustained firing through inhibiting an apamin-insensitive
level, nanomolar concentrations of kisspeptin induce a strong depolarization and intensive firing of GnRH neurons (18, 31, 42, 59) . Indeed, kisspeptin neurons provide the most potent excitatory input to GnRH neurons, and in vivo administration of kisspeptins induces surge-like LH secretion in several species (16, 20, 36, 45) .
GnRH is released in an episodic or pulsatile manner, and it is thought that neurosecretory (e.g., GnRH) neurons fire in a sustained bursting mode to augment peptide release such as during a "surge" (2, 12, 21, 23, 33, 37) . Recently, It was reported that the calcium-activated, slow afterhyperpolarization currents (I sAHP ) are critical for the expression of burst firing in GnRH neurons (29) .
There are three kinds of calcium-activated potassium channels that mediate afterhyperpolarizations based on their kinetics: the fast AHP mediated by large-conductance Ca 2ϩ -activated K ϩ channels; the medium AHP (mAHP) mediated by small-conductance Ca 2ϩ -activated K ϩ (SK) channels; and the slow AHP (sAHP) mediated by a yet unidentified potassium channel that is regulated by many neurotransmitters (4, 46, 47, 54) . GnRH neurons express a mAHP current and both an apamin-sensitive and an apamin-insensitive I sAHP (5, 8, 22, 29, 30, 51) . In most central neurons, the mAHP controls action potential discharge frequency, whereas the sAHP is largely responsible for producing spike frequency adaptation, i.e., decreased firing in the face of a sustained depolarizing stimulus (47) . However, in GnRH neurons the I sAHP have been reported to regulate both action potential discharge frequency and spike frequency adaptation (29) .
Kisspeptin depolarizes GnRH neurons via the coupling of G protein-coupled receptor 54 (GPR54) to a phospholipase C (PLC) signaling pathway that activates nonselective canonical transient receptor potential (TRPC) channels that allow influx of calcium ions (59) . Because the calcium influx would activate the I sAHP and attenuate firing, we hypothesized that kisspeptin would inhibit the calcium-activated I sAHP and stimulate burst firing and ultimately peptide release. Indeed, we have found that kisspeptin inhibits an apamin-insensitive I sAHP in GnRH neurons through a protein kinase C (PKC)-dependent signaling pathway that affects bursting activity.
MATERIALS AND METHODS
Animals and treatments. All animal treatments described in this study are in accordance with institutional guidelines based on National Institutes of Health standards and were performed with institutional Animal Care and Use Committee approval at the Oregon Health and Science University. Transgenic female mice expressing enhanced green fluorescent protein under the control of the GnRH promoter were used in these studies (52) . Animals were group-housed until surgery at which time they were housed individually. All animals were maintained under controlled temperature and photoperiod (lights on at 0600 and off at 1800) and given free access to food and water. Adult (2-to 5-mo-old) females were ovariectomized under isoflurane inhalation anesthesia. After ϳ7 days, the animals were treated with 17␤-estradiol benzoate to induce positive feedback as described (6) . Animals were killed at 1000 -1100 at which time the uterus was removed and weighed as a measure of plasma 17␤-estradiol levels (7). Recordings were done from 1300 to 1800 during the afternoon.
Peparation of preoptic area GnRH slices. Mice were killed quickly by decapitation. The brain was rapidly removed from the skull, and a block containing the diagonal band (DB)-preoptic area (POA) was immediately dissected. The DB-POA block was submerged in cold (4°C) oxygenated (95% O 2-5% CO2) high-sucrose cerebrospinal fluid (CSF, in mM): 208 sucrose, 2 KCl, 26 NaHCO 3, 10 glucose, 1.25 NaH 2PO4, 2 MgSO4, 1 MgCl2, and 10 HEPES, pH 7.4, 290 mosm. Coronal slices (200 m) from the DB-POA were cut on a vibratome during which time (10 min) the slices were bathed in high-sucrose CSF at 4°C. The slices were then transferred to an auxiliary chamber where they were kept at room temperature (25°C) in artificial CSF (aCSF) consisting of (in mM): 124 NaCl, 5 KCl, 2.6 NaH 2PO4, 2 MgCl 2, 2 CaCl2, 26 NaHCO3, 10 HEPES, and 10 glucose, pH 7.4, 310 mosm until recording (recovery for 2 h). A single slice was transferred to the recording chamber at a time and was kept viable by continually perfusing with warm (35°C), oxygenated aCSF at 2 ml/min.
Visualized whole cell patch recording. Whole cell patch recordings were made with a Zeiss Axioskop FS upright microscope equipped with fluorescence (fluorescein isothiocyanate filter set) and infrared differential interference contrast imaging devices. GnRH neurons were identified by the method described in our previous papers (57) (58) (59) . Patch pipettes (1.5 mm OD borosilicate glass; A-M Systems) were pulled on a Brown/Flaming puller (model P-97; Sutter Instrument) and were filled with the following internal solution (in mM): 130 KMeSO4, 5 Na2 phosphocreatine, 10 KCl, 1 MgCl2, 0.025 EGTA, 10 HEPES, 2.5 ATP, and 0.25 GTP adjusted to pH 7.3 with KOH; 290 mosm. Pipette resistances were 2-3 M⍀ when filled with the above pipette solution. In the whole cell configuration, access resistance was 10 -25 M⍀. Voltage-clamp experiments were performed with an Axopatch 1D amplifier (2-10 kHz lowpass filter; Axon Instruments, Foster City, CA). Under voltage-clamp configuration, cells were voltage clamped at a holding potential of Ϫ60 mV. IsAHP was elicited once every 60 s by 600-ms-long depolarizing step commands to ϩ40 mV. The medium AHP current (ImAHP) was elicited once every 30 s by 100-ms-long depolarizing step commands. In current clamp, the sAHP following a train of action potentials was induced by 20 pulses of 300 pA in amplitude and 3 ms in duration delivered at 20 Hz. Each measurement was repeated 10 times, and the signals were averaged. The mean resting membrane potential of GnRH neurons measured with low-EGTA (25-50 M) internal solution was Ϫ65.9 Ϯ 1.0 mV (n ϭ 17), which is about 3 mV more negative than that measured with high EGTA (11 mM) internal solution (57) . The reported membrane potentials have been corrected for the liquid junction potential of 10 mV. Under current-clamp configuration, the spike frequency adaptation properties before and after kisspeptin application were evaluated by examining the current injection-induced firing from the "clamped" initial membrane potential of Ϫ65 mV. First, the amount of current required to depolarize the cell membrane to a threshold level of action potential firing (rheobase) was examined by current pulses with step increments of 5 pA. Next, repeated firing was induced by current pulses of 2ϫ rheobase amplitude. Electrophysiological signals were digitized with Digidata 1322A (Axon Instruments), and the data were analyzed using Clampfit 9.2 software (Axon Instruments).
Electrophysiological solutions/drugs. aCSF was used in all cases for electrophysiological recording. In whole cell voltage-clamp recordings, tetrodotoxin (TTX) was used to isolate the effect of presynaptic input. Different drug stock solutions were diluted 1,000-fold in aCSF to their final concentrations in 20-ml syringes and were delivered by a Gilson Mini-Plus Pump with a perfusion rate of 2 ml/min. Kisspeptin-10 [Mouse Kiss-1(110 -119)-NH2; Kp-10] was purchased from Phoenix Pharmaceuticals (Belmont, CA) and dissolved in water to a stock concentration of 100 M. Apamin (240 M in stock) and TTX (1 mM in stock) were purchased from Alomone Laboratories (Jerusalem, Israel) and were dissolved in water. Forskolin (10 mM in stock), phorbol 12,13-dibutyrate (PDBu, 1 mM in stock), calphostin C (500 M stock solution), H-89 (10 mM stock solution), and 3-(triphenylmethylaminomethyl)pyridine, (UCL-2077, 10 mM stock solution) were purchased from Tocris (Ellisville, MO) and dissolved in dimethyl sulfoxide. The Rp diastereomer of adenosine 3=,5=-cyclic monophosphorothioate (Rp-cAMPS; Sigma-Aldrich, St. Louis, MO) was dissolved in the internal solution.
Electrophysiology data measurement and analysis. The I sAHP was measured at its peak. Only cells with stable initial IsAHP greater than 15 pA were included in the study. The control IsAHP for each recording was the average of two to three pulses before drug application. The after-drug IsAHP was the average of two to three pulses after 5-8 min drug application. Data were analyzed and plotted using Clampfit 9.2, Macromedia Freehand 10, GraphPad Prism 4, and Sigma Plot 8.0 software. Comparisons between different treatments were performed using an unpaired Student's t-test or a one-way or two-way ANOVA with Bonferroni posttests. Differences were considered significant if the probability of error was Ͻ5%. All data were presented as means Ϯ SE.
RESULTS

Kisspeptin reduces spike frequency adaptation in GnRH neurons. Kisspeptin excites GnRH neurons through the activation of TRPC channels and inhibition of inwardly rectifying K
ϩ (K ir ) channels, which robustly depolarizes GnRH neurons to cause continuous firing (59) . Because most central nervous system (CNS) neurons exhibit spike frequency adaptation, which is the decreased firing with continued stimulus, we decided to measure the effects of kisspeptin on spike frequency adaptation. For these experiments, we current clamped the membrane potential to Ϫ65 mV, which is the resting membrane potential of GnRH neurons, and we established the rheobase current for generating firing (Fig. 1) . A 10-s current injection of 2ϫ rheobase induced early burst firing followed by quiescence or reduced firing after 0.5 s, indicative of robust spike frequency adaptation. However, with bath application of kisspeptin (Kp-10, 10 nM), an identical depolarizing stimulus (2ϫ rheobase current) caused a significantly longer burst of action potentials lasting for the duration of the pulse (Fig. 1A) . In the presence of kisspeptin, the remaining sAHP at the end of the pulse most likely resulted from the kisspeptin-insensitive component. Figure 1B summarizes the effect of kisspeptin on the induced firing rate over several stimulation durations (0.5, 2, and 10 s) at 2ϫ rheobase. Kisspeptin had no effect on the induced firing rate when the current injection duration was shorter than 0. 5 s, but it dramatically increased the firing rate for longer durations (2 and 10 s). Therefore, kisspeptin reduces spike frequency adaptation and prolongs burst firing duration in GnRH neurons. Figure 1C shows an example recording of kisspeptin's ability to increase the firing rate and decrease the interspike interval (ISI) even when the membrane potential was brought back to the prekisspeptin level by current injection to offset TRPC channel activation. The ISI analysis in Fig. 1D clearly shows that kisspeptin increased the firing rate via depolarization and elimination of the long ISI or interburst interval.
Kisspeptin inhibits I sAHP through a PKC signaling pathway.
Because the I sAHP governs spike frequency adaptation in CNS neurons (13, 32) , we assessed the effects of kisspeptin on the I sAHP in GnRH neurons. To quantify the effects of kisspeptin on the I sAHP , a voltage-clamp protocol that steps from Ϫ60 to ϩ40 mV for 600 ms was used since this is needed to fully activate the I sAHP in GnRH neurons (30) . We found that this protocol, which was delivered every minute, induced a reproducible response ( Fig. 2A) . Cells that exhibited an I sAHP greater than 15 pA were examined for the effects of kisspeptin. As shown in Fig. 2B , the GnRH neuron exhibited stable peak I sAHP currents of 23 pA before kisspeptin application. After 3 min kisspeptin application, the I sAHP was strongly inhibited by 54%, and concurrently kisspeptin induced an inward current of 37 pA, mainly because of the activation of TRPC channels (59) . Figure 2C shows the time course of the kisspeptin inhibition of the peak I sAHP and the lack of an effect of the vehicle control over the same time period. Kisspeptin reduced the mean I sAHP by 50.8% (from 25.2 Ϯ 1.6 to 12.4 Ϯ 2.1 pA, n ϭ 16) within 10 min, whereas the I sAHP only decreased slightly (6.7%) with vehicle perfusion over the same time period (Fig. 2D) . We also examined the effect of kisspeptin on the I sAHP in current-clamp recordings. As shown in Fig. 2E , a train of 20 action potentials at 20 Hz induced an sAHP that lasted about 10 s. Kisspeptin application inhibited the sAHP. The summary data in Fig. 2F show that kisspeptin significantly decreased the sAHP by 50% (from 3.8 Ϯ 0.7 to 1.9 Ϯ 0.4 mV, n ϭ 5, P Ͻ 0.05).
Next we examined the signaling pathway through which kisspeptin inhibited the I sAHP in GnRH neurons. In central neurons, I sAHP is inhibited by neurotransmitters that activate protein kinase A (PKA) or PKC signaling pathways (35, 41, 54) . The kisspeptin receptor GRP54 is a G q -coupled receptor that activates PKC (25, 31, 59) . Therefore, we asked whether kisspeptin inhibits I sAHP through a PKC signaling pathway and examined the effects of both PKC activators and PKC inhibitors. As shown in Fig. 3 , the PKC activator PDBu (1 M) mimicked the effects of kisspeptin and further occluded any effects of kisspeptin on the I sAHP (Fig. 3, A, C, and F) . Moreover, the PKC inhibitor calphostin C abrogated the inhibitory effects of kisspeptin on the I sAHP (Fig. 3, B and F) . We also examined the effects of a PKA activator and two inhibitors on the I sAHP . Following pretreatment with the PKA catalytic subunit inhibitor H-89 (10 M for 1-2 h) or whole cell dialysis with the regulatory subunit inhibitor Rp-cAMP for 10 min, kisspeptin still inhibited the I sAHP by 57.5 Ϯ 7.2% (n ϭ 6) and 59.3 Ϯ 7.3% (n ϭ 4), respectively, which was not significantly different from the effects of kisspeptin alone (Fig. 3, D and F) . As a positive control for H-89 (10 M), the same pretreatment abrogated the effects of the PKA activator forskolin (10 M) to inhibit I sAHP (4.5 Ϯ 4.1% for H-89 ϩ forskolin vs. 63.5 Ϯ 4.2% for forskolin alone, P Ͻ 0.001) (Fig. 3F) . Therefore, these pharmacological experiments indicate that kisspeptin inhibits I sAHP through activating a PKC but not a PKA signaling pathway.
Kisspeptin inhibits the apamin-insensitive I sAHP . It has been reported that GnRH neurons express both an apamin-sensitive I sAHP and an apamin-insensitive I sAHP (22, 29) . Therefore, to examine whether kisspeptin inhibits the apamin-insensitive I sAHP , we first examined the effects of kisspeptin on the apamin-insensitive currents after apamin application. As shown in Fig. 4A , a concentration of apamin (240 nM) that generates a maximum response (22, 29) inhibited the total I sAHP by ϳ50%, and Kp-10 inhibited the residual current such that the combined inhibition was 87%. We next examined the effects of apamin in the presence of kisspeptin. As shown in Fig. 4B , a concentration of kisspeptin (10 nM) that generates a maximum depolarization (59) inhibited the total I sAHP by ϳ50%, and the residual I sAHP was inhibited by apamin (240 nM) such that the combined inhibition was 86%. The summary data in Fig. 4C document that kisspeptin and apamin inhibited the total I sAHP by 49.5 Ϯ 7.7% (n ϭ 16) and 49.8 Ϯ 8.6% (n ϭ 9), respectively, and the combination of kisspeptin and apamin inhibited the I sAHP by 84.9 Ϯ 3.4% (n ϭ 8). Interestingly, an I mAHP was clearly evident (Fig. 4, Aii and 4Bii) and, as expected, was inhibited by apamin (Fig. 4Aii) , whereas kisspeptin did not affect the I mAHP (Fig. 4Bii) . In addition, we found that GnRH neurons exhibited a clear I mAHP when a shorter (100 ms) voltage-step protocol was used. We used this protocol to document that 240 nM apamin completely inhibited the medium AHP within 5 min (95.7 Ϯ 2.2%, n ϭ 3) (Fig. 4D) . Therefore, because apamin (240 nM) was fully efficacious to inhibit the medium AHP but only partially inhibits the I sAHP , an apamin-insensitive I sAHP must be expressed in GnRH neurons. UCL-2077 has been found to inhibit an apamin-insensitive I sAHP in hippocampal and GnRH neurons (29, 48) . Thus, we examined its effects on the apamin-insensitive I sAHP . GnRH neurons were pretreated with apamin (240 nM) in the recording chamber for 20 -30 min before UCL-2077 application. As shown in Fig. 4 , E and F, the apamin-insensitive I sAHP activated slowly. The mean time to reach the peak of the I sAHP was 2.1 Ϯ 0.5 s (n ϭ 7), and the time constant for decay was 7,242.5 Ϯ 6.8 ms (n ϭ 9). UCL-2077 (10 M) only partially inhibited the apamin-insensitive I sAHP with a mean inhibition of 37.8 Ϯ 12.2% (n ϭ 6). In contrast, 10 nM kisspeptin almost completely inhibited the apamin-insensitive I sAHP with a mean inhibition of 90.8 Ϯ 4.6% (n ϭ 6, P Ͻ 0.001 vs. UCL-2077) (Fig. 4, F and G) . Therefore, 10 nM Kp-10 fully inhibits an apamin-insensitive I sAHP in GnRH neurons. Moreover, to examine if kisspeptin preferentially inhibits I sAHP over activating TRPC channels at lower concentrations, we examined the effects of 3 nM Kp-10 (an EC 50 concentration for kisspeptin to induce an inward current). Kp-10 (3 nM) also inhibited the apamin-insensitive I sAHP by about 50% (57.0 Ϯ 8.6%, n ϭ 3). Therefore, the EC 50 values for kisspeptin's inhibition of the apamin-insensitive I sAHP and activation of TRPC channels are similar.
DISCUSSION
Since the initial studies showing that kisspeptin has longlasting effects to prolong firing of GnRH neurons (18, 31, 42, 59) , the question has been why is there little spike frequency adaption? In this study, we show for the first time that kisspeptin inhibits an apamin-insensitive I sAHP in GnRH neurons, which reduces spike frequency adaptation and prolongs burst firing. These effects of kisspeptin on I sAHP are mediated via the activation of a PKC signaling pathway. Therefore, in addition to depolarizing GnRH neurons through activating TRPC channels and inhibiting K ir channels, kisspeptin prolongs burst firing of GnRH neurons by inhibiting the I sAHP .
The I sAHP is a Ca 2ϩ -activated K ϩ current that follows a long burst of action potentials. It can also be elicited by depolarizing pulses of hundreds of milliseconds that activate high-voltagegated calcium channels. This I sAHP current peaks in several hundred milliseconds, decays with a time constant from 1 to 10 s, and is not sensitive to apamin inhibition in most neurons (4, 46, 47, 54) . However, GnRH neurons have been found to express both an apamin-insensitive I sAHP and an apaminsensitive I sAHP (22, 29, 30, 51) (present findings). It is most likely that the SK channel mediates the apamin-sensitive I sAHP (and I mAHP ) in GnRH neurons (1) . Indeed, a relatively high level of expression of SK3 transcripts is found in native GnRH neurons (6) .
The molecular identity of the apamin-insensitive I sAHP has not been ascertained, but it is modulated by a plethora of neurotransmitters and neuropeptides via activation of PKA, PKC, or calmodulin kinase II (13, 19, 38 -41, 46, 54) . For monoamine neurotransmitters (e.g., norepinephrine, serotonin, and dopamine), the inhibition of the I sAHP involves upregulation of cAMP and the subsequent activation of PKA (41) . Some neuropeptides such as corticotropin-releasing hormone and vasoactive intestinal peptide also inhibit the I sAHP through activating a cAMP-PKA signaling pathway (19) . In thalamic paraventricular nucleus neurons, the I sAHP is modulated by both PKA and PKC activity (60) . However, in GnRH neurons, the selective PKA inhibitors Rp-cAMPS and H-89 did not attenuate the effects of kisspeptin. In contrast, the broadspectrum PKC inhibitor calphostin C abrogated the effects of kisspeptin, and PDBu occluded the effects of kisspeptin. This is analogous to the kainate receptor-mediated inhibition of I sAHP in CA1 pyramidal neurons via activation of PKC (17, 35) . Our findings are also consistent with the pathway elucidated in both heterologous cell expression systems and in native GnRH neurons in which kisspeptin has been shown to signal via the G q -coupled GPR54 to stimulate PLC, activate PKC, and increase cytosolic calcium oscillations (10, 25, 26, 31, 59) .
At the cellular level, the I sAHP limits the firing that underlies the late phase of spike frequency adaptation and is a major player in controlling neuronal excitability (13, 32) . Inhibition of I sAHP by neurotransmitters reduces spike frequency adaptation and increases the duration and firing rate during burst firing (13, 14, 44, 60) . Our results clearly show that kisspeptin inhibited an apamin-insensitive I sAHP and reduced spike frequency adaptation in GnRH neurons. The pyridine UCL-2077 is thought to inhibit the apamin-insensitive I sAHP in GnRH neurons (29) . However, we found that UCL-2077 (10 M) only partially inhibited the apamin-insensitive I sAHP , which is consistent with the effects reported by Shah et al. (48) in hippocampal CA1 neurons. Also, UCL-2077 is not selective for the I sAHP since it potentiates KCNQ 5 channels that underlie the M current (50) , which confounds the effects of UCL on GnRH neurons since they express KCNQ 5 channels and a robust M current (55) . Therefore, the endogenous neurotrans- Fig. 4 . Kisspeptin inhibits an apamin-insensitive IsAHP in GnRH neurons. Ai: a representative recording showing that apamin (240 nM) inhibited the peak IsAHP by 50%, and the residual current was inhibited by Kp-10 (10 nM; total inhibition 87%). Aii: superimposition of the IsAHP traces before (control) and after apamin and Kp-10 applications. The medium AHP current is indicated by the arrow. Bi: a representative recording showing that kisspeptin inhibited 50% of the peak IsAHP, and the remaining component was inhibited by apamin (total inhibition 86%). Bii: superimposition of the IsAHP traces before (control) and after Kp-10 and apamin applications. The medium AHP currents are indicated by the arrows. C: summary of the percent inhibition by Kp-10, apamin, and the combined application of Kp-10 and apamin (Kp-10 ϩ apamin) on the total IsAHP. *P Ͻ 0.05 and **P Ͻ 0.01 compared with the Kp-10 ϩ apamin group mitter kisspeptin is the most efficacious inhibitor of the apamin-insensitive I sAHP in GnRH neurons.
It is well known that GnRH is released in a pulsatile manner, and the hypothalamic surge of GnRH and subsequent pituitary release of LH are required for triggering ovulation in the female. Although single action potential-induced calcium influx is enough to spark the release of classical transmitters, burst firing or tetanic stimulation is required for the release of neuropeptides such as vasopressin, oxytocin, substance P, and atrial natriuretic factor (3, 34, 49) . Previous studies have shown that kisspeptin robustly depolarizes and increases the firing of GnRH neurons through a combination of activating TRPC channels and attenuating K ir conductances (31, 42, 58, 59) . In the present study, we show for the first time that kisspeptin can also modulate burst firing duration by inhibiting an apamininsensitive I sAHP . Therefore, the combination of the depolarization by activating TRPC and inhibiting K ir channels and an apamin-insensitive I sAHP would greatly facilitate burst firing that would contribute to the preovulatory surge of GnRH peptide.
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